NASDAQ:NURO
Delisted

Neurometrix Stock News

etoro logo Buy NURO
*Your capital is at risk
$4.58
+0 (+0%)
At Close: Jul 30, 2025
The stock price of Neurometrix Inc (NASDAQ: NURO) increased by over 30% pre-market. This is why it happened.
These most-shorted stocks have more than just apes to do their bidding, they offer earnings power and price charts to buy. The post 3 Most-Shorted Stocks to Buy After Earnings Beats appeared first on
NURO stock is an interesting opportunity for sure. But it may be best to wait for it to head back to single-digit prices before buying.
NURO stock received attention from Reddit, but it should interest investors because of its other positive characteristics. The post NueroMetrix Stock Looks Strong Following Its Positive Catalysts appe
NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q2 2021 Results - Earnings Call Transcript

Why NeuroMetrix Stock Is Soaring Today

09:45am, Thursday, 22'nd Jul 2021
NeuroMetrix Inc (NASDAQ: NURO) is surging higher Thursday morning after the company announced better-than-expected financial results.  NeuroMetrix reported a second-quarter earnings loss of 13 cents

NURO Stock Increased 107.17%: Why It Happened

07:47am, Thursday, 22'nd Jul 2021
The stock price of Neurometrix Inc (NASDAQ: NURO) increased by 107.17% yesterday. This is why it happened.

Why NeuroMetrix Shares Are Skyrocketing Today

01:57pm, Wednesday, 21'st Jul 2021
NeuroMetrix (NASDAQ:NURO) shares are trading higher by 153% at $25.41 on continued upward momentum after the company announced that its Quell device has received Breakthrough Designation from the FDA
Neurometrix Inc. (NASDAQ:NURO) shares flew higher Tuesday and Wednesday on continued momentum after the company announced its Quell device received Breakthrough Designation from the FDA for treating t
We're seeing lots of activity from penny stock PainReform (PRFX) on Wednesday despite a lack of news from the pharmaceutical company. The post PRFX Stock: 7 Things to Know About Pharmaceutical Company
NURO stock is continuing its price-doubling into today. Retail investors have caught wind of NURO short selling and flocked to buy in.
Shares of NeuroMetrix Inc. rocketed 241% toward a two-year high on record volume, after the Massachusetts-based medical device company said its Quell transcutaneous electric nerve stimulator received
The stock price of Neurometrix Inc (NASDAQ: NURO) increased by 173% during intraday trading. This is why it happened.
Neurobo Pharmaceuticals (NRBO) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company. The post NRBO Stock: 6 Things to Know About NeuroBo Pharma as Retail Investors
NeuroMetrix Inc's (NASDAQ: NURO) Quell device has received Breakthrough Designation from the FDA to treat fibromyalgia symptoms in adults. Fibromyalgia is a common form of chronic pain accompanied
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE